Par Pharmaceutical Announces the Resignation of Its Chief Financi... ( WOODCLIFF LAKE N.J. Dec. 12 /- Par Ph...)

Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer

Date:12/12/2008

WOODCLIFF LAKE, N.J., Dec. 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced the resignation of Veronica A. Lubatkin, executive vice president and chief financial officer, effective March 6, 2009, to pursue other professional opportunities.

Lawrence A. Kenyon, 43, will join Par on December 15th as executive vice president of finance and will assume the role of chief financial officer on March 9, 2009. Mr. Kenyon joins from Alfacell Corporation where he served as president, chief financial officer and corporate secretary since joining the company in 2006. Mr. Kenyon will remain on the board of directors of Alfacell and, in this capacity, will also serve as acting president, chief financial officer and corporate secretary until January 31, 2009. Prior to joining Alfacell, he served as executive vice president, chief financial officer and corporate secretary of NeoPharm Inc. since 2000. From 1988 until 2000, Mr. Kenyon held a variety of senior executive positions with Mathers & Company, Inc. and its affiliated companies most recently as a chief financial officer. Mr. Kenyon, a certified public accountant, began his career with Arthur Andersen & Co. after receiving a bachelor's degree in accounting from the University of Wisconsin -- Whitewater.

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.

SafeHarbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Bi-Coastal Pharmaceutical Corp. Acquires U.S. Marketing Rights to Aquoral(TM) Artificial Saliva Product
2. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
3. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
4. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
5. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
6. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
7. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
8. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
9. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
10. Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe
11. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference

Post Your Comments:

(Date:5/22/2013)... May 22, 2013 Hurricane preparation isn’t ... home. That’s why Amica Insurance is reminding ... the upcoming hurricane season. , “An important part of ... Cook, a senior assistant vice president at Amica Insurance. ... before the threat of a storm.” , Flood damage ...

(Date:5/22/2013)... trustworthy, loving child care is one of the most important ... parents in their search, Paty’s Daycare has launched a ... staff and much more. , “Our new website is vibrant, ... Patricia “Auntie Paty” Sutton, founder of Paty’s Daycare. “Just as ... from the first time that you walk through the front ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...

(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... who die each year awaiting an organ donation dropped ... numbers of children are receiving donor organs. During ... expanded to include not just patients who,ve experienced brain ... death." But it,s unclear how much that shift ...

(Date:5/22/2013)... oil supplements could help reduce the risk for ... The supplements, also known as omega-3 fatty acids, ... linked to insulin sensitivity, Harvard researchers found. Higher ... also been linked to a lower risk for ... fish oil increased circulating adiponectin, whether similar effects ...

Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2 Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2 Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4 Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2

[0] Reviewing Insurance Policies: a Key Part of Hurricane Preparations [0] Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care [0] Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats [0] More Kids Getting Donor Organs, But Gaps Persist, Study Finds [0] Fish Oil Pills Might Cut Diabetes Risk, Researchers Say

... Ill., Nov. 12 Pregis Corporation, a leading international ... specialty packaging solutions, today announced its 2009 third quarter ... of 2009, the Company generated net sales of $207.0 ... $265.2 million in the third quarter of 2008. Excluding ...

... protein involved in blood-brain barrier , THURSDAY, Nov. 12 ... on the brain, but it,s too early to say ... researcher reports. , Fredrik Soderqvist, of Orebro University, analyzed ... they had elevated levels of a protein called transthyretin, ...

... eating dark version lowered levels of stress hormones , THURSDAY, ... dark chocolate could cheer you right up by lowering your ... who report their findings in the online issue of the ... said they were highly stressed. , "The study provides strong ...

... ... P.C. has opened its new facility in Lake Success, NY. The facility will ... Epilepsy Neurologist Alan B. Ettinger, M.D., Neuro-Ophthalmologist Scott Uretsky, M.D., Neuropsychologist Gad E. ... children’s facility designed for the needs of pediatric patients. , ...

... Healthcare is an industry faced with unprecedented uncertainty. ... overcome the noise and clearly communicate relevant and timely ... company Griffin York & Krause (GY&K) reaffirmed its commitment ... been honored with six national CardioVascular Advertising (CVA) Awards. ...

... BEACH, Fla., Nov. 12 Commerce Online Inc. (Pink ... company specializing in both bricks and mortar and online ... partnership with RedFin Network, Inc. ( www.redfinnet.com ... Inc. (OTC Bulletin Board: SFNL), to launch its ...

Pregis Announces Third Quarter 2009 Financial Results Wireless Phones Alter Levels of Brain Chemical Chocolate Soothes the Stressed-Out Soul Neurological Surgery, P.C., of Long Island, NY, Adds New Specialists and Opens New Flagship Facility in Lake Success, NY Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?'Commerce Online Announces Agreement With RedFin Network For Medical Marijuana Dispensary Pre-Paid Loyalty Card Program

(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...

(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...

(Date:5/22/2013)... Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company ... medical needs, today announced the appointment of ... Board of Directors. Dr. Almenoff has extensive experience in ... drug development. "We are delighted to ... Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise ...

Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6 Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2 Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3

[0] Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance [0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives [0] Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors

... LOUIS, May 2, 2012 Stereotaxis, Inc. (NASDAQ: ... release financial results for the first quarter 2012 ... of the U.S. financial markets. The Company will ... a.m. Eastern Time that day to discuss the ...

... OMER ), a biopharmaceutical company committed to ... and disorders of the central nervous system, today announced ... officer, is scheduled to present at the Deutsche Bank ... presentation is scheduled for 10:00 a.m. Eastern Time on ...

Cached Medicine Technology:Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 2 Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 3

Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 Omeros to Present at Deutsche Bank Securities Health Care Conference

... is a service that directly connects ... the customers laboratory to the Thermo ... U.S.A., and Runcorn, U.K.* By using ... customer site, high-value support services are ...

... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...

... The Shandon Gross-Star Grossing Workbench ... workbench designed for gross examination and ... steel construction, downdraft ventilation with a ... foot pedal controls for cold/hot water ...

... HypercleanTM 22 fume containment system ... a one- or two-person work ... containment system comes complete ... four charcoal filters. (For replacement ...

Medicine Products:

Shandon Excelsior Netmon Service Shandon Grosslab Senior Grossing Workstation Shandon Gross-Star Grossing Workbench Shandon Hyperclean 22 Fume Handling Station